| 000 | 01458 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250515111109.0 | ||
| 264 | 0 | _c20080415 | |
| 008 | 200804s 0 0 eng d | ||
| 022 | _a1574-8928 | ||
| 024 | 7 |
_a10.2174/157489208783478711 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTyndall, Joel D A | |
| 245 | 0 | 0 |
_aPeptides and small molecules targeting the plasminogen activation system: towards prophylactic anti-metastasis drugs for breast cancer. _h[electronic resource] |
| 260 |
_bRecent patents on anti-cancer drug discovery _cJan 2008 |
||
| 300 |
_a1-13 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeoplasm Metastasis _xprevention & control |
| 650 | 0 | 4 |
_aPeptides _xpharmacology |
| 650 | 0 | 4 |
_aReceptors, Cell Surface _xantagonists & inhibitors |
| 650 | 0 | 4 | _aReceptors, Urokinase Plasminogen Activator |
| 650 | 0 | 4 |
_aSerine Proteinase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aUrokinase-Type Plasminogen Activator _xantagonists & inhibitors |
| 700 | 1 | _aKelso, Michael J | |
| 700 | 1 | _aClingan, Phillip | |
| 700 | 1 | _aRanson, Marie | |
| 773 | 0 |
_tRecent patents on anti-cancer drug discovery _gvol. 3 _gno. 1 _gp. 1-13 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/157489208783478711 _zAvailable from publisher's website |
| 999 |
_c17793305 _d17793305 |
||